tiprankstipranks
Hansoh Pharmaceutical Group Company Limited (HK:3692)
:3692
Hong Kong Market
3692
Hansoh Pharmaceutical Group Company Limited
RESEARCH TOOLSreports

Hansoh Pharmaceutical Group Company Limited (3692) Ratios

7 Followers

Hansoh Pharmaceutical Group Company Limited Ratios

HK:3692's free cash flow for Q2 2025 was ¥0.91. For the 2025 fiscal year, HK:3692's free cash flow was decreased by ¥ and operating cash flow was ¥0.42. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 8.09 10.18 4.21 9.86 7.67
Quick Ratio
 7.95 9.94 4.12 9.69 7.53
Cash Ratio
 0.78 8.39 3.27 6.72 4.86
Solvency Ratio
 1.30 1.59 0.50 0.40 0.42
Operating Cash Flow Ratio
 0.27 1.43 0.45 1.05 0.85
Short-Term Operating Cash Flow Coverage
 20.52 94.49 0.74 0.00 0.00
Net Current Asset Value
¥ 31.03B¥ 24.46B¥ 21.64B¥ 18.48B¥ 16.05B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 0.13 0.15 0.14
Debt-to-Equity Ratio
 <0.01 <0.01 0.17 0.19 0.19
Debt-to-Capital Ratio
 <0.01 <0.01 0.14 0.16 0.16
Long-Term Debt-to-Capital Ratio
 0.00 0.00 <0.01 0.16 0.16
Financial Leverage Ratio
 1.13 1.10 1.28 1.32 1.36
Debt Service Coverage Ratio
 80.82 74.94 0.87 44.15 47.27
Interest Coverage Ratio
 3.58K 602.65 42.58 45.94 54.84
Debt to Market Cap
 <0.01 <0.01 0.05 0.06 0.04
Interest Debt Per Share
 0.02 0.02 0.70 0.75 0.66
Net Debt to EBITDA
 -0.57 -5.26 -4.32 -4.52 -3.53
Profitability Margins
Gross Profit Margin
89.93%90.98%89.80%90.73%91.24%
EBIT Margin
36.07%31.83%37.93%27.79%28.39%
EBITDA Margin
38.62%34.89%41.56%31.25%31.04%
Operating Profit Margin
36.08%32.88%28.10%28.47%29.15%
Pretax Profit Margin
43.64%41.48%37.27%31.43%33.22%
Net Profit Margin
37.01%35.66%32.44%27.54%27.31%
Continuous Operations Profit Margin
37.01%35.66%32.44%27.54%27.31%
Net Income Per EBT
84.81%85.97%87.03%87.63%82.21%
EBT Per EBIT
120.95%126.15%132.64%110.38%113.93%
Return on Assets (ROA)
13.82%13.81%9.92%8.61%9.99%
Return on Equity (ROE)
16.59%15.24%12.71%11.41%13.54%
Return on Capital Employed (ROCE)
15.14%13.92%10.85%9.76%12.00%
Return on Invested Capital (ROIC)
12.82%11.94%8.13%8.54%9.86%
Return on Tangible Assets
13.94%13.92%9.97%8.62%9.99%
Earnings Yield
2.76%4.54%3.66%3.33%2.96%
Efficiency Ratios
Receivables Turnover
 4.87 3.84 3.13 2.62 2.70
Payables Turnover
 4.49 5.07 6.29 3.91 3.50
Inventory Turnover
 2.46 1.70 1.79 1.94 2.12
Fixed Asset Turnover
 4.64 3.78 3.08 2.69 2.78
Asset Turnover
 0.37 0.39 0.31 0.31 0.37
Working Capital Turnover Ratio
 0.51 0.52 0.45 0.43 0.57
Cash Conversion Cycle
 141.82 238.14 262.49 233.83 202.90
Days of Sales Outstanding
 75.00 95.05 116.61 139.21 135.05
Days of Inventory Outstanding
 148.18 215.03 203.87 187.87 171.99
Days of Payables Outstanding
 81.35 71.93 57.98 93.24 104.14
Operating Cycle
 223.17 310.08 320.48 327.08 307.04
Cash Flow Ratios
Operating Cash Flow Per Share
 0.20 0.65 0.50 0.46 0.44
Free Cash Flow Per Share
 0.18 0.61 0.46 0.42 0.36
CapEx Per Share
 0.02 0.04 0.04 0.05 0.08
Free Cash Flow to Operating Cash Flow
 0.90 0.94 0.93 0.90 0.82
Dividend Paid and CapEx Coverage Ratio
 0.60 1.86 3.58 2.78 3.06
Capital Expenditure Coverage Ratio
 9.82 17.40 14.19 10.05 5.60
Operating Cash Flow Coverage Ratio
 11.22 32.76 0.72 0.63 0.67
Operating Cash Flow to Sales Ratio
 0.08 0.32 0.31 0.29 0.26
Free Cash Flow Yield
0.53%3.78%3.23%3.18%2.31%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 37.42 22.01 27.33 30.00 33.77
Price-to-Sales (P/S) Ratio
 13.99 7.85 8.86 8.26 9.22
Price-to-Book (P/B) Ratio
 5.83 3.36 3.47 3.42 4.57
Price-to-Free Cash Flow (P/FCF) Ratio
 196.66 26.44 30.92 31.40 43.28
Price-to-Operating Cash Flow Ratio
 174.91 24.92 28.74 28.28 35.55
Price-to-Earnings Growth (PEG) Ratio
 2.53 0.46 2.00 -6.90 7.43
Price-to-Fair Value
 5.83 3.36 3.47 3.42 4.57
Enterprise Value Multiple
 35.64 17.24 17.01 21.93 26.18
Enterprise Value
 198.34B 73.74B 71.43B 64.28B 80.75B
EV to EBITDA
 34.46 17.24 17.01 21.93 26.18
EV to Sales
 13.31 6.01 7.07 6.85 8.13
EV to Free Cash Flow
 187.14 20.26 24.66 26.04 38.14
EV to Operating Cash Flow
 168.09 19.09 22.92 23.45 31.33
Tangible Book Value Per Share
 5.90 4.79 4.08 3.82 3.38
Shareholders’ Equity Per Share
 5.90 4.84 4.11 3.83 3.38
Tax and Other Ratios
Effective Tax Rate
 0.15 0.14 0.13 0.12 0.18
Revenue Per Share
 2.49 2.07 1.61 1.59 1.68
Net Income Per Share
 0.92 0.74 0.52 0.44 0.46
Tax Burden
 0.85 0.86 0.87 0.88 0.82
Interest Burden
 1.21 1.30 0.98 1.13 1.17
Research & Development to Revenue
 0.22 0.22 0.21 0.18 0.18
SG&A to Revenue
 0.32 0.37 0.07 0.06 0.09
Stock-Based Compensation to Revenue
 <0.01 0.01 0.02 0.02 <0.01
Income Quality
 0.25 0.88 0.95 1.06 0.95
Currency in CNY